Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials

Randomized clinical trials are considered the milestones of clinical research in oncology, and guided the development and approval of new compounds so far. In the last few years, however, molecular and genomic profiling led to a change of paradigm in therapeutic algorithms of many cancer types, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Liello, Raimondo, Piccirillo, Maria Carmela, Arenare, Laura, Gargiulo, Piera, Schettino, Clorinda, Gravina, Adriano, Perrone, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618758/
https://www.ncbi.nlm.nih.gov/pubmed/34833129
http://dx.doi.org/10.3390/life11111253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618758/
https://www.ncbi.nlm.nih.gov/pubmed/34833129
http://dx.doi.org/10.3390/life11111253

Ejemplares similares